CSPC announces IND approval for mpox mRNA vaccine SYS-6037

CSPC Pharmaceutical Group Ltd. has announced IND approval from the FDA for SYS-6037 injection, its mpox mRNA vaccine codeveloped with the Institute of Microbiology of the Chinese Academy of Sciences.